Cipla launches Nintib (Nintedanib) to treat Idiopathic Pulmonary Fibrosis EP News Bureau Oct 20, 2020 Cipla’s Nintib is priced at Rs 69 (100 mg) and Rs. 85 (150 mg) per capsule
Glenmark launches NINDANIB (nintedanib) for pulmonary fibrosis in India EP News Bureau Oct 14, 2020 Two clinical trials are being rolled out to study the efficacy and safety of Nintedanib as a treatment of SARS-COV2 induced…
DCGI approves Nintedanib for the treatment of systemic sclerosis-associated interstitial lung… EP News Bureau May 20, 2020 Approval is based on the SENSCIS study which showed Nintedanib slows the loss of pulmonary function in people living with systemic…
